<DOC>
	<DOC>NCT01228006</DOC>
	<brief_summary>It is hoped that the group treated with Panax Ginseng, Vitamins and Minerals obtain significant reduction in levels of stress and fatigue and that the results are superior to the placebo group.</brief_summary>
	<brief_title>Study for Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals (NatugerinÂ®) in Improvement of Stress and Fatigue</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<criteria>Agree with all study procedures, signing the IC in two ways, by his own free will; Patients older than 18 years, male or female, regardless of ethnicity or social class; Presence of pictures of mild to moderate stress, confirmed with the aid of the Stress Symptom Inventory (ISS), which considers stress and mild to moderate classification Alert classification Resistance; Presence frame of fatigue with a score greater than 36 according to the Fatigue Severity Scale (FSS). Participation in clinical trials in the 12 months preceding the survey; Current treatment with drugs that are stimulants or central nervous system depressants such as hypnotics, anxiolytics, antipsychotics, antidepressants, statins and muscle relaxants; Alternative Therapies that scientifically, or have no influence in the tables of stress or fatigue as acupuncture or relaxing massages; Treatment psychotherapeutic medication or not; Current treatment or prediction of treatment with oral anticoagulants (due to interaction with the tocopherol); Women who are pregnant or lactating; Patients with lactose intolerance; Patients allergic to soy or peanuts; chronic renal failure; Patients using other multivitamins or individual vitamins such as vitamin D and / or A. Chronic alcoholism; Patients with clinical diagnosis of diseases causing severe chronic pain or adversely affect the clinical interpretation as fibromyalgia, multiple sclerosis, neuropathies and myopathies; Patients with hypothyroidism or hyperthyreosis diagnosed clinically; Patient history and physical examination suggestive of severe hepatorenal failure; Patients with decompensated diabetes mellitus (fasting glucose above 180 mg / dL); Patients being treated for cancer; Amendment of the routine of life during the study as early vacation or suspected change in working hours; Patients with complaints of excessive sleepiness caused by organic source frameworks such as sleep apnea and morbid obesity (BMI above 35); History of hypersensitivity to any component of the product under investigation; Any finding of clinical observation (clinical history or physical examination) that is interpreted by the physician investigator as a risk to the patient's participation in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Reduction of stress and fatigue</keyword>
</DOC>